HEAMGEN Inc. is a spin-out of Giostar, Inc., a recognized leader in the field of stem cells and regenerative therapies and products.
GIOSTARS’s vision is to provide human stem-cell based therapy to aid all those around the world who are suffering from various types of degenerative and genetic diseases such as Parkinson’s, Alzheimer’s, autism, diabetes, heart and blood related diseases, strokes, spinal cord injuries, paralysis, cancer and skin burns. GIOSTAR’s primary focus is to discover and develop treatments for such diseases with advanced stem cell-based therapies and products. Through its worldwide development of strategically located stem cell research clinics and hospitals. GIOSTAR ultimate aim is to continue to maintain its leadership in the field of stem cell science and to develop affordable delivery systems for the global masses unable to afford the usually high cost of the treatment.
GIOSTAR’s mission is to administer the safest and most effective stem cell therapies and to deliver the highest quality care through its hospitals.
GIOSTAR will continue to maintain its position of industry leadership through its pioneering research capabilities. GIOSTAR ensures the highest quality care and treatment through rigorous quality control and management. At the same time, GIOSTAR ensures that its operations are efficient, profitable and generate substantial returns for its shareholders. GIOSTAR will continue to value its patients, researchers, scientists, physicians and employees and treat them with the utmost respect. GIOSTAR values teamwork and rewards all contributions that drive our success. GIOSTAR aims to operate with the highest levels of integrity. GIOSTAR also plans to give back to the community in a significant and measurable way by developing programs that will make the treatments affordable to those who are less fortunate and in need.